Predictmedix Inc.
PMEDF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $35 | $35 |
| % Growth | – | -100% | 0% | – |
| Cost of Goods Sold | $0 | $168 | $8 | $8 |
| Gross Profit | $0 | -$168 | $27 | $27 |
| % Margin | – | – | 76% | 76% |
| R&D Expenses | $0 | $0 | $83 | $73 |
| G&A Expenses | $579 | $1,088 | $1,555 | $1,555 |
| SG&A Expenses | $788 | $1,745 | $1,849 | $1,849 |
| Sales & Mktg Exp. | $125 | $389 | $294 | $509 |
| Other Operating Expenses | $0 | $0 | -$118 | $169 |
| Operating Expenses | $788 | $1,745 | $1,815 | $2,092 |
| Operating Income | -$788 | -$1,745 | -$2,065 | -$1,652 |
| % Margin | – | – | -5,896.3% | -4,718.3% |
| Other Income/Exp. Net | -$388 | -$248 | -$3 | -$230 |
| Pre-Tax Income | -$1,176 | -$1,993 | -$2,068 | -$1,882 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,176 | -$1,993 | -$2,068 | -$1,882 |
| % Margin | – | – | -5,904.5% | -5,374.6% |
| EPS | -0.008 | -0.014 | -0.018 | -0.017 |
| % Growth | 43.9% | 23.2% | -4% | – |
| EPS Diluted | -0.008 | -0.014 | -0.018 | -0.017 |
| Weighted Avg Shares Out | 150,269 | 142,931 | 114,168 | 107,925 |
| Weighted Avg Shares Out Dil | 150,259 | 142,926 | 114,168 | 107,925 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $9 | $3 | $3 |
| Depreciation & Amortization | $155 | $40 | $159 | $79 |
| EBITDA | -$788 | -$1,872 | -$1,905 | -$1,803 |
| % Margin | – | – | -5,441% | -5,148.2% |